Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.50p
  • 52 Week Low: 5.62p
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 691,010
  • Market Cap: £31.68m
  • RiskGrade: 348
  • Beta: 0.59

Latest Deals

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
10-Dec-24 Buy James Renwick McCullough 8.50p 25,000 £2,125.00
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
05-Dec-24 Buy James Renwick McCullough 7.50p 53,300 £3,997.50
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 17,061,345 £1,236,948
James Renwick McCullough 3,242,096 £235,052
Robert (Rob) Graham Naylor 693,318 £50,266
Fergus Fleming 569,481 £41,287
Catherine Coste 385,129 £27,922

Major Shareholders

Notifier** Holding Value*
Heights Capital Management, Inc. 43,151,533 £3,128,486
UBS Group AG 34,900,846 £2,530,311
CVI Holdings, LLC 33,000,000 £2,392,500
Ruffer LLP 28,500,000 £2,066,250
Unicorn Asset Management Limited 25,797,882 £1,870,346
UBS Group AG 22,590,196 £1,637,789
Harwood Capital LLP 17,061,345 £1,236,948
Harwood Capital LLP 14,609,946 £1,059,221
Polar Capital, LLP 13,196,197 £956,724
Icahn School of Medicine at Mount Sinai 10,750,926 £779,442
Jefferson River Capital LLC 8,294,932 £601,383
Mount Sinai 8,018,986 £581,376
Gilder Gagnon Howe and Co LLC 6,042,634 £438,091
Forest Nominees Limited 4,001,187 £290,086
Lombard Odier & Co Ltd 2,952,334 £214,044
Amati Global Investors 2,455,247 £178,005
Fidelity Investment International 2,173,851 £157,604

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 7.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.50p
52 Week Low 5.62p
Volume 691,010
Shares Issued 437.02m
Market Cap £31.68m
Beta 0.59
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 05-Nov-2025

Time Volume / Share Price
16:20 10,403 @ 7.05p
16:18 36,134 @ 7.05p
15:40 2,820 @ 7.09p
14:56 5,050 @ 7.00p
13:41 250,000 @ 7.00p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page